1.Buysschaert M, Medina JL, Bergman M, Shah A, Lonier J. Prediabetes and associated disorders. Endocrine. 2015;48(2):371–93.
2.Tuso P. Prediabetes and lifestyle modification: time to prevent a preventable disease. The Permanente journal. 2014;18(3):88–93.
3.Tabak AG, Herder C, Rathmann W, Brunner EJ, Kivimaki M. Prediabetes: a high-risk state for diabetes development. Lancet (London, England). 2012;379(9833):2279–90.
4.Ferrannini E. Definition of intervention points in prediabetes. The lancet Diabetes & endocrinology. 2014;2(8):667–75.
5.ADA. American Diabetes Association: Standards of Medical Care in Diabetes - 2018. Journal of Clinical and Applied Research and Education. 2018;41(Supp. 1).
6.Goldenberg R, Punthakee Z. Definition, classification and diagnosis of diabetes, prediabetes and metabolic syndrome. Canadian journal of diabetes. 2013;37 Suppl 1:S8–11.
7.Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes care. 2003;26 Suppl 1:S5–20.
8.Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabetic medicine: a journal of the British Diabetic Association. 1998;15(7):539–53.
9.Kharroubi AT, Darwish HM, Abu Al-Halaweh AI, Khammash UM. Evaluation of glycated hemoglobin (HbA1c) for diagnosing type 2 diabetes and prediabetes among Palestinian Arab population. PloS one. 2014;9(2):e88123.
10. American Diabetes Association Position statement: Standards of Medical Care in Diabetes–2010. Diabetes Care, 2010; 33(Suppl.1), S11–61.
11.World Health Organization. Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia: report of a WHO/IDF consultation. WHO, 2006.
12.Ovbiagele B. TACKLING THE GROWING DIABETES BURDEN IN SUB-SAHARAN AFRICA: A FRAMEWORK FOR ENHANCING OUTCOMES IN STROKE PATIENTS. Journal of the neurological sciences. 2015;348(0):136–41.
13.Mayega RW, Guwatudde D, Makumbi F, Nakwagala FN, Peterson S, Tomson G, et al. Diabetes and Pre-Diabetes among Persons Aged 35 to 60 Years in Eastern Uganda: Prevalence and Associated Factors. PloS one. 2013;8(8).
14.Tabák AG. Prediabetes: A high-risk state for developing. 2012;379(9833):2279–90.
15.Jun JE, Lee SE, Lee YB, Jee JH, Bae JC, Jin SM, et al. Increase in serum albumin concentration is associated with prediabetes development and progression to overt diabetes independently of metabolic syndrome. PloS one. 2017;12(4).
16.Perreault L, Faerch K. Approaching pre-diabetes. Journal of diabetes and its complications. 2014;28(2):226–33.
17.Brannick B, Wynn A, Dagogo-Jack S. Prediabetes as a toxic environment for the initiation of microvascular and macrovascular complications. Experimental Biology and Medicine. 2016;241(12):1323–31.
18.Lott MEJ, Slocomb JE, Shivkumar V, Smith B, Quillen D, Gabbay RA, et al. Impaired Retinal Vasodilator Responses in Prediabetes and Type 2 Diabetes. Acta ophthalmologica. 2013;91(6):e462–9.
19.Nunes S, Soares E, Fernandes J, Viana S, Carvalho E, Pereira FC, et al. Early cardiac changes in a rat model of prediabetes: brain natriuretic peptide overexpression seems to be the best marker. Cardiovascular Diabetology. 2013;12:44.
20.Eklioğlu BS. Prediabetes and Cardiovascular Parameters in Obese Children and Adolescents. 2016;8(1):80–5.
21.Huang D. Macrovascular Complications in Patients with Diabetes and Prediabetes. 2017;2017.
22.Grundy SM. Pre-diabetes, metabolic syndrome, and cardiovascular risk. Journal of the American College of Cardiology. 2012;59(7):635–43.
23.Cullmann M, Hilding A, Ostenson CG. Alcohol consumption and risk of pre-diabetes and type 2 diabetes development in a Swedish population. Diabetic medicine: a journal of the British Diabetic Association. 2012;29(4):441–52.
24.Yin Y, Han W, Wang Y, Zhang Y, Wu S, Zhang H, et al. Identification of Risk Factors Affecting Impaired Fasting Glucose and Diabetes in Adult Patients from Northeast China. International journal of environmental research and public health. 2015;12(10):12662–78.
25.Davidson MB, Duran P, Lee ML. Community screening for pre-diabetes and diabetes using HbA1c levels in high-risk African Americans and Latinos. Ethnicity & disease. 2014;24(2):195–9.
26.Tillmann FP, Quack I, Schenk A, Grabensee B, Rump LC, Hetzel GR. Prevalence and risk factors of pre-diabetes after renal transplantation: a single-centre cohort study in 200 consecutive patients. Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association - European Renal Association. 2012;27(8):3330–7.
27.Kim JY, Michaliszyn SF, Nasr A, Lee S, Tfayli H, Hannon T, et al. The Shape of the Glucose Response Curve During an Oral Glucose Tolerance Test Heralds Biomarkers of Type 2 Diabetes Risk in Obese Youth. Diabetes care. 2016;39(8):1431–9.
28.Mahtab N, Farzad H, Mohsen B, Nakisa D. The 10-year trend of adult diabetes, prediabetes and associated risk factors in Tehran: Phases 1 and 4 of Tehran Lipid and Glucose Study. Diabetes & metabolic syndrome. 2017;11(3):183–7.
29.Satman I, Omer B, Tutuncu Y, Kalaca S, Gedik S, Dinccag N, et al. Twelve-year trends in the prevalence and risk factors of diabetes and prediabetes in Turkish adults. European journal of epidemiology. 2013;28(2):169–80.
30.Huang D, Refaat M, Mohammedi K, Jayyousi A, Al Suwaidi J, Abi Khalil C. Macrovascular Complications in Patients with Diabetes and Prediabetes. BioMed research international. 2017;2017:7839101.
31.Mayega RW, Guwatudde D, Makumbi F, Nakwagala FN, Peterson S, Tomson G, et al. Diabetes and pre-diabetes among persons aged 35 to 60 years in eastern Uganda: prevalence and associated factors. PloS one. 2013;8(8):e72554.
32.Man REK, Charumathi S, Gan ATL, Fenwick EK, Tey CS, Chua J, et al. Cumulative incidence and risk factors of prediabetes and type 2 diabetes in a Singaporean Malay cohort. Diabetes research and clinical practice. 2017;127:163–71.